Articles |
From the Institut National de la Santé et de la Recherche Médicale (INSERM), Unit 141, IFR "Circulation Lariboisière," Paris, France.
Correspondence to Dr Bernard Lévy, INSERM Unit 141, Hôpital Lariboisière, 75010 Paris, France.
Abstract To investigate the relation between the tissue reninangiotensin system (RAS) and the local vasomotor tone of large arteries, we used in vitro isolated carotid arteries from 14-week-old Wistar-Kyoto rats (WKY; n=80) and spontaneously hypertensive rats (SHR; n=80). Diameters were measured with the use of an ultrasonic echo-tracking system (12 MHz) under flow (2 mL/min) (F+) or no-flow (Fo) conditions, with intact endothelium (Endo+) or after endothelium removal (Endo-). The role of tissue RAS was assessed by incubating isolated carotid arteries with an angiotensin-converting enzyme inhibitor (ACE I; lisinopril, 10-6 mol/L) or with a specific antagonist of angiotensin II AT1 receptors (AT1A; losartan, 10-6 mol/L). In addition, maximal dilation of carotid arteries was measured after poisoning with KCN (100 mg/L). In all experiments, KCN significantly increased carotid diameters (WKY, 23±0.9%; SHR, 19±0.8%; P<.001 versus control conditions). In intact carotid arteries, flow caused significant dilation in WKY (7±0.5%, P<.001) but had no effect in SHR. In the presence or absence of flow, ACE I and AT1A induced similar dilations in both strains, and a specific antagonist of bradykinin B2 receptors (Hoe 140, 10-7 mol/L) had no effect on ACE Iinduced dilation. After endothelium removal, carotid artery diameters were significantly increased (P<.001) in both strains, although more in SHR (13±0.8%) than in WKY (8±1.1%) (P<.001). Also, flow did not modify the diameter of deendothelialized vessels and ACE I had no effect in either strain. In contrast, AT1A increased diameters further (WKY, 4±0.4%; SHR, 3±0.6%; P<.01). The results of the present study suggest that in in vitro isolated intact carotid artery, (1) the endothelium exerts a basal vasoconstrictor effect that is larger in SHR than in WKY, which could participate in the relative insensitivity to flow in SHR; (2) in the absence of exogenous substrate the vessel wall is able to produce angiotensin II, which is active locally on the vascular tone; and (3) inhibition of angiotensin II formation, not degradation of bradykinin, appears to be responsible for the local relaxing effect of ACE inhibition.
Key Words: ACE inhibitor angiotensin AT1 receptor flow wall artery in vitro isolated carotid artery
This article has been cited by other articles:
![]() |
S. G. Denniss and J. W. E. Rush Impaired hemodynamics and endothelial vasomotor function via endoperoxide-mediated vasoconstriction in the carotid artery of spontaneously hypertensive rats Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H1038 - H1047. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. B. Wilkinson, A. Qasem, C. M. McEniery, D. J. Webb, A. P. Avolio, and J. R. Cockcroft Nitric Oxide Regulates Local Arterial Distensibility In Vivo Circulation, January 15, 2002; 105(2): 213 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. H. Schiffers, D. Henrion, C. M. Boulanger, E. Colucci-Guyon, F. Langa-Vuves, H. van Essen, G. E. Fazzi, B. I. Levy, and J. G. R. De Mey Altered Flow-Induced Arterial Remodeling in Vimentin-Deficient Mice Arterioscler Thromb Vasc Biol, March 1, 2000; 20(3): 611 - 616. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Matrougui, L. Loufrani, C. Heymes, B. I. Levy, and D. Henrion Activation of AT2 Receptors by Endogenous Angiotensin II Is Involved in Flow-Induced Dilation in Rat Resistance Arteries Hypertension, October 1, 1999; 34(4): 659 - 665. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Marano, M. Grigioni, S. Palazzesi, and A. U Ferrari Endothelin and mechanical properties of the carotid artery in Wistar-Kyoto and spontaneously hypertensive rats Cardiovasc Res, March 1, 1999; 41(3): 701 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Safar, G. M. London, R. Asmar, and E. D. Frohlich Recent Advances on Large Arteries in Hypertension Hypertension, July 1, 1998; 32(1): 156 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. H. R. Wolffenbuttel, C. M. Boulanger, F. R. L. Crijns, M. S. P. Huijberts, P. Poitevin, G. N. M. Swennen, S. Vasan, J. J. Egan, P. Ulrich, A. Cerami, et al. Breakers of advanced glycation end products restore large artery properties in experimental diabetes PNAS, April 14, 1998; 95(8): 4630 - 4634. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Joannides, V. Richard, W. E. Haefeli, A. Benoist, L. Linder, T. F. Luscher, and C. Thuillez Role of Nitric Oxide in the Regulation of the Mechanical Properties of Peripheral Conduit Arteries in Humans Hypertension, December 1, 1997; 30(6): 1465 - 1470. [Abstract] [Full Text] |
||||
![]() |
K. Matrougui, J. Maclouf, B. I. Levy, and D. Henrion Impaired Nitric Oxide– and Prostaglandin-Mediated Responses to Flow in Resistance Arteries of Hypertensive Rats Hypertension, October 1, 1997; 30(4): 942 - 947. [Abstract] [Full Text] |
||||
![]() |
D. Henrion, J. Benessiano, and B. I. Levy In Vitro Modulation of a Resistance Artery Diameter by the Tissue Renin-Angiotensin System of a Large Donor Artery Circ. Res., February 1, 1997; 80(2): 189 - 195. [Abstract] [Full Text] |
||||
![]() |
D. Henrion, F. J. Dowell, B. I. Levy, and J.-B. Michel In Vitro Alteration of Aortic Vascular Reactivity in Hypertension Induced by Chronic NG-Nitro-L-Arginine Methyl Ester Hypertension, September 1, 1996; 28(3): 361 - 366. [Abstract] [Full Text] |
||||
![]() |
L. Caputo, J. Benessiano, C. M. Boulanger, and B. I. Levy Angiotensin II Increases cGMP Content Via Endothelial Angiotensin II AT1 Subtype Receptors in the Rat Carotid Artery Arterioscler Thromb Vasc Biol, October 1, 1995; 15(10): 1646 - 1651. [Abstract] [Full Text] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |